A phase I, randomized, open-Label, crossover study evaluating pharmacokinetics of Mirogabalin when coadministered with probenecid and cimetidine in healthy adult volunteers

Trial Profile

A phase I, randomized, open-Label, crossover study evaluating pharmacokinetics of Mirogabalin when coadministered with probenecid and cimetidine in healthy adult volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jun 2018

At a glance

  • Drugs Mirogabalin (Primary) ; Cimetidine; Probenecid
  • Indications Neurogenic pain; Pain; Postherpetic neuralgia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 19 Jun 2018 Results assessing the individual effects of probenecid and cimetidine on mirogabalin exposure published in the British Journal of Clinical Pharmacology
    • 05 Apr 2017 New trial record
    • 18 Mar 2017 Results evaluating pharmacokinetic interaction between Cimetidine with Mirogabalin, presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top